ReBlood Rx LLC
ReBlood Rx is dedicated to innovating oxygen therapy through hemoglobin-based solutions, aiming to provide a safe, effective, and reliable oxygen delivery system in medical emergencies where blood transfusions are not an option. Their mission focuses on improving patient outcomes in critical care settings and addressing the challenges of blood supply shortages in both human and veterinary medicine.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Hemoglobin-based oxygen carrier (HBOC) product
A hemoglobin-derived oxygen-carrying formulation intended for use when donor blood is not an option; designed for emergency, surgical, veterinary, and remote care applications with extended shelf life and universal compatibility.
Hemoglobin-based oxygen carrier (HBOC) product
A hemoglobin-derived oxygen-carrying formulation intended for use when donor blood is not an option; designed for emergency, surgical, veterinary, and remote care applications with extended shelf life and universal compatibility.
Services
Execution of small-animal efficacy/safety studies and planning/plausible execution of comprehensive large-animal safety studies in preparation for GLP-compliant data generation.
Planning and coordination for scaling production, including evaluating and working with contract manufacturing organizations to develop a scalable manufacturing plan for hemoglobin-based products.
Execution of small-animal efficacy/safety studies and planning/plausible execution of comprehensive large-animal safety studies in preparation for GLP-compliant data generation.
Planning and coordination for scaling production, including evaluating and working with contract manufacturing organizations to develop a scalable manufacturing plan for hemoglobin-based products.
Expertise Areas
- Hemoglobin-based oxygen carrier development
- Veterinary clinical development
- Preclinical safety testing (small and large animal models)
- GMP manufacturing and scale-up
Key Technologies
- Hemoglobin-based oxygen carriers (HBOCs)
- Protein purification (hemoglobin extraction)
- Formulation stabilization for ambient storage
- Freeze-storage formulations for stockpiling
News & Updates
ReBlood Rx is excited to enter the last quarter of the year, working diligently to bring their innovation to the world. They express gratitude to Tina Bova for connecting them with Madigan Army Medical Center, which will support their future efforts.
ReBlood Rx thanks the Center for Veterinary Medicine for granting an ADUFA Fee Waiver, saving over $900,000, and shares updates on their participation in various programs and events.
FDA Fee Waiver
ReBlood Rx received an ADUFA Fee Waiver from the Center for Veterinary Medicine, saving over $900,000, promoting innovation in veterinary medicine.
Participation in 757 Accelerate
CEO Carlos Munoz participated in the 757 Accelerate program, preparing to pitch to various Angel groups in October.
ReBlood Rx is excited to enter the last quarter of the year, working diligently to bring their innovation to the world. They express gratitude to Tina Bova for connecting them with Madigan Army Medical Center, which will support their future efforts.
ReBlood Rx thanks the Center for Veterinary Medicine for granting an ADUFA Fee Waiver, saving over $900,000, and shares updates on their participation in various programs and events.
FDA Fee Waiver
ReBlood Rx received an ADUFA Fee Waiver from the Center for Veterinary Medicine, saving over $900,000, promoting innovation in veterinary medicine.
Participation in 757 Accelerate
CEO Carlos Munoz participated in the 757 Accelerate program, preparing to pitch to various Angel groups in October.